Been looking at healthcare stocks lately and honestly, most people sleep on this sector when it comes to dividend plays. But there are some solid names worth checking out if you've got a spare grand or less to deploy.

Becton, Dickinson caught my attention first. This is what they call a Dividend King - meaning it's bumped up its payout every single year for over 50 years straight. That's the kind of consistency most investors dream about. The company isn't flashy like some of the GLP-1 darlings out there, but it's more of a foundational play. They make the basics - syringes, medical devices, that kind of thing. Not headline-grabbing stuff, but essential.

They've had a rough patch recently, not gonna lie. But they just spun off a division that wasn't working out, and they've got new products in the pipeline that should help turn things around. The yield is sitting at 2.4%, which is well above what you'd get from the broader market. For people thinking in terms of decades, this could be worth a look while Wall Street's still skeptical.

Then there's Medtronic. This one's just a couple years away from hitting Dividend King status itself, so the track record is pretty solid. The yield here is even better at 2.9%. Like Becton, Dickinson, they've been working through some headwinds, but something's shifting. They recently launched surgical robots into the U.S. market, and that's potentially huge. Intuitive Surgical basically built an entire premium valuation (63x P/E) on surgical robotics dominance. Medtronic's trading at 27x, which seems reasonable given their broader business mix. If the market starts pricing in the robotics opportunity, there's room for upside.

Here's the practical part: a thousand bucks gets you into either of these. You could grab five shares of Becton, Dickinson or ten shares of Medtronic with that amount. Both could fit nicely into a healthcare dividend portfolio. The thing is, both have catalysts brewing that could push valuations higher, so it might not be the best idea to sit on the sidelines too long.